FBLG Q4 2025 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

FBLGFibroBiologics, Inc. Common Stock

$17M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$234,000

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$702,000

Balance Sheet

Total Assets

$10M

Total Liabilities

$3M

Stockholders' Equity

$6M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$234,000	$0	—
Operating Income	-$3M	-$4M	+30.2%
Net Income	-$3M	-$3M	-4.7%